Revenue generated by 999 Ganmao Ling in conventional pharmacies in China 2017-2021
Between January and September 2021, the pharmaceutical company China Resource Sanjiu generated 1.38 billion yuan of revenue through the sales of 999 Ganmao Ling in brick-and-mortar pharmacies in China. The revenue contributed by the drug surpassed two billion yuan in 2019, before declining slightly in 2020. 999 Ganmao Ling is a widely-used Chinese patent drug in China, treating common colds and fever.